Atherectomy devices were developed to permit drilling, grinding, or sanding of atheroma, calcium, and excess cellular material from the site of coronary occlusion or stenosis. Both mechanical and laser-based approaches are used. It is a minimally invasive procedure similar to angioplasty. It is performed to cut away plaque that has built up in the arteries. After the plaque is removed, a stent may be placed to keep the artery open. The continuous rise in the artery blockage in the geriatric population and the cardiovascular diseases give rise to number of atherectomy procedures hence increasing the target market. As the atherectomy procedure is easy, less infectious and has a minimal surgery procedure and complications, it is more preferred over the surgical procedures.
Region Analysis:
In this target market, North America has the largest share in the global atherectomy device market followed by other regions. This can be attributed to high prevalence of the peripheral and coronary artery diseases combined with the large number of patients with life-style related complications are the primary factors leading to the dominance of North American market.
Key Development:
• Boston Scientific Corporation acquired Vascular interventional device division of Bayer AG for $415 million in cash.
• In 2020, Angio Dynamics launched their Auryon Atherectomy System in the U.S. The device is based on solid-state laser technology.
Before purchasing this report, request a sample or make an inquiry by clicking the following link:
https://www.prophecymarketinsights.com/market_insight/Insight/reque...
Segmentation:
The Global Atherectomy Device Market accounted for US$ 541.65 billion in 2020 and is estimated to be US$ 1207.81 billion by 2030 and is anticipated to register a CAGR of 8.4%. The Global Atherectomy Device Market is segmented by Device Type, Disease Site, Application, End User and Region.
• Based on device type, the global atherectomy device market is classified into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, and laser atherectomy devices.
• On the basis of diseases site, the target market is categorized as coronary artery disease and peripheral artery disease.
• On the basis of application, the target market is segmented as cardiovascular atherectomy devices, neurovascular devices and peripheral vascular atherectomy devices.
• On the basis of end user global atherectomy device market is divide into hospitals, clinics and ambulatory surgical centers.
Competitive Analysis:
The key players operating in the global atherectomy device market includes Bayer HealthCare, Inc., Boston Scientific Corporation, C. R. Bard, Inc., Cardinal Health, Cardiovascular Systems, Inc., Spectranetics, Philips Holding USA, Inc., Straub Medical AG, Abbott Laboratories and Terumo Interventional Systems.

Other Related Reports:-

https://chaitanyafb.blogspot.com/2022/12/instant-noodles-market-is-...

https://sites.google.com/view/instant-noodles-market-21/home?read_c...

https://www.reddit.com/r/unitedstatesofindia/comments/zx1fki/instan...